Reckitt Benckiser Group has filed a patent for a composition encapsulated in a soft gelatin shell containing ibuprofen, polyoxysorbitan esters, and a base. The weight ratios and specific ingredients are outlined for optimal effectiveness. GlobalData’s report on Reckitt Benckiser Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Reckitt Benckiser Group Plc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Reckitt Benckiser Group, Water-soluble detergent packaging was a key innovation area identified from patents. Reckitt Benckiser Group's grant share as of January 2024 was 51%. Grant share is based on the ratio of number of grants to total number of patents.

Soft gelatin shell composition with ibuprofen and polyoxysorbitan esters

Source: United States Patent and Trademark Office (USPTO). Credit: Reckitt Benckiser Group Plc

A patent application (Publication Number: US20240016750A1) discloses a composition designed for encapsulation in a soft gelatin shell. The composition includes 50%-65% w/w ibuprofen, one or more polyoxysorbitan esters, and a base. The weight ratios of the polyoxysorbitan esters to ibuprofen, base to ibuprofen, and polyoxysorbitan esters to base are specified within a range. The composition may further contain water in a specific amount and have a unit dose weight ranging from 300-420 mg. Additionally, the release rate of ibuprofen from the composition is highlighted, with specific percentages within a specified time frame.

Moreover, the patent application details variations in the composition, such as different weight ratios of ingredients, unit dose weights, and fill volumes. The composition may consist essentially of specific percentages of ibuprofen, polyoxysorbitan esters, hydroxide, and water. The application also mentions the use of the composition in a soft gelatin capsule, specifying the solubilization rate of ibuprofen in simulated gastric fluid. The types of polyoxysorbitan esters that can be used in the composition are listed, along with a solvent system comprising polyoxysorbitan esters, potassium hydroxide, and water. The patent application provides a comprehensive overview of the composition and its various formulations for use in soft gel capsules.

To know more about GlobalData’s detailed insights on Reckitt Benckiser Group, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.